Gainers Buzz: H&R Block, Inc. (NYSE:HRB), Cadence Design Systems, Whirlpool Corporation, Valeant Pharmaceuticals

Lakeway, NY -- (SBWIRE) -- 03/05/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

H&R Block, Inc. (NYSE:HRB) moved up 2.66% and closed at $25.44. So far this year, the stock is up over 37%. The 52-week range for the stock is $14.35 and $25.50. H&R Block, Inc. has subsidiaries that provide tax preparation and banking services. The Company's Tax Services segment provides assisted income tax return preparation, digital tax solutions and other services and products related to income tax return preparation to the general public primarily in the United States, and also in Canada and Australia.

Is HRB a Still a Buy after the Solid momentum? Let’s Find out Here

Cadence Design Systems Inc. (NASDAQ:CDNS) increased 2.65% and closed at $14.31. The 52-week range for the stock is $9.73 and $14.54. The Company has Price/Sales ratio of 3.04 and Price/Book ratio of 4.39. The 50-Day Moving Average and 200-Day Moving Average prices is $14.10 and $13.30 respectively.

Is CDNS a Strong Buying Opportunity After The Recent Slump? Find out Here

Whirlpool Corporation (NYSE:WHR) climbed up 2.63% and closed at $117.36. The 52-week range for the stock is $54.08 and $115.67. Whirlpool Corp said Chairman and Chief Executive Jeff Fettig's 2012 compensation increased 29% on sharply higher cash bonuses linked to the appliance maker's performance. Mr. Fettig's salary, incentive-based pay, executive perks, stock awards and the value of his pension amounted to $15.9 million. Whirlpool Corporation is a manufacturer and marketer of home appliances. Whirlpool operates in four segments: North America, Latin America, EMEA and Asia.

Should WHR Buy After The Recent Movement? Let’s Find out Here

Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) increased 2.63% and closed at $69.41. AMBI Skincare announced the annual AMBI Research Award with The Skin of Color Society, a grant of $15,000 to promote dermatology research within the field of skin of color. AMBI and the Skin of Color Society are helping to shape the future of tomorrow's clinical leaders in dermatology, expressly in this specialized field. AMBI Skincare is one of the brands under Valeant Pharmaceuticals North America.

Should VRX Buy After The Recent Movement? Let’s Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.